title: Bioreactors get personal.
abstract: Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individualized cell therapies. Such bioreactors might increase the number of patients that get access to this promising therapeutic modality.
authors.affiliation: Surgery Branch; National Cancer Institute; National Institutes of Health; Bethesda, MD USA.
authors.forename: Robert P T
authors.initials: RP
authors.lastname: Somerville
authors.forename: Mark E
authors.initials: ME
authors.lastname: Dudley